Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Provides 2016 Outlook

SAN RAMON, Calif., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
January 11, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at NobleCon12 - Noble Financial Capital Markets’ Twelfth Annual Investor Conference

SAN RAMON, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
January 07, 2016 09:25 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants

SAN RAMON, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
January 06, 2016 16:25 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants

SAN RAMON, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
December 24, 2015 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces a Change to Its Board of Directors

SAN RAMON, Calif., Dec. 24, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
December 18, 2015 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Sell Zuplenz® (ondansetron) Oral Soluble Film, Completing Divestiture of Commercial Operations

SAN RAMON, Calif., Dec. 18, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
December 11, 2015 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Departure of Chief Financial Officer

SAN RAMON, Calif., Dec. 11, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
December 08, 2015 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Presents Final GALE-401 Phase 2 Clinical Data at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition

SAN RAMON, Calif., Dec. 8, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
December 04, 2015 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Settlement of Securities Class Action and Shareholder Derivative Lawsuits

SAN RAMON, Calif., Dec. 4, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
November 30, 2015 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Oppenheimer 26th Annual Healthcare Conference

SAN RAMON, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...